Our in vitro studies demonstrated that NRBF2 knock-down had detrimental effects in Pods, GECs, MCs and PTCs and, in contrast, indicated that increased NRBF2 expression in podocytes protected against actin remodelling induced by insulin resistance. Here, NRBF2 is linked to Insulin resistance.